Skip to content

Survey research on the body perception of the general adult male population

Survey research on the body perception of the general adult male population - Survey research on the body perception of the general adult male population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000054151
Enrollment
330
Registered
2024-05-01
Start date
2024-05-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

None listed

Sponsors

Allm Inc.
Lead Sponsor
DeNA Life Science, Inc.
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Healthy adult males 2) Those who have already given written consent to participate in the MYCODE study. 3) Who have been fully informed of the purpose and content of this study, have the capacity to consent, and are willing and able to voluntarily agree to participate in this study upon full understanding of the purpose and content of the study. 4) Those who are able to come to the clinic on the designated examination date and undergo the examination.

Exclusion criteria

Exclusion criteria: 1) Persons taking high blood pressure medication. 2) Persons wearing a pacemaker or other medical electrical device. 3) Persons with severe anemia. 4) Persons who are judged to be inappropriate as subjects by the principal investigator and the principal researcher.

Design outcomes

Primary

MeasureTime frame
Body perception

Secondary

MeasureTime frame
Volunteer background Life skills scale for adolescents and adults International physical activity questionnaire Type A tendency discrimination chart Core LUTS symptom score International index of erectile function Aging males' symptoms scale Perceived stress scale Apparent age Blood test results Urinalysis results

Countries

Japan

Contacts

Public ContactTatsuya Matsuda

Allm Inc. Medical Pharma DX Department

IRB_dls@dena.com03-4361-2650

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026